This suggests that analysts have very recently bumped up their estimates for INCY, giving the stock a Zacks Earnings ESP of +40.11% heading into earnings season. Why is this Important? A positive reading for the Zacks Earnings ESP …
Exelixis (NASDAQ: EXEL) is without question one of the hottest biotech stocks on the market. We're talking about a stock that has more than tripled in value in just the last 12 months and has soared over 70% so far this year. Exelixis is, …
Shares of Incyte Corporation closed the previous trading session at 132.00 up +3.30 2.56% with 1,038,399 shares trading hands. The post Insider Trading Activity Incyte Corporation (NASDAQ:INCY) – Insider Sold 3,000 shares of Stock …
Jan 31 (Reuters) - Incyte Corp: * SYROS PHARMACEUTICALS -‍ ON JAN 31, ENTERED AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENT WITH INCYTE TO FACILITATE PRIVATE PLACEMENT - SEC FILING * SYROS …